OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

HIKMA PHARMACEUTIC.LS-,10/  GB00B0LCW083  /

Lang & Schwarz
2024-11-06  10:43:44 PM Chg. -0.600 Volume Bid10:43:44 PM Ask10:43:44 PM Market Capitalization Dividend Y. P/E Ratio
21.400EUR -2.73% -
Turnover: -		 21.400Bid Size: - 22.000Ask Size: - 4.6 bill.EUR - -

Assets

 2019
IFRS
in mill. USD		 2020
IFRS
in mill. USD		 2021
IFRS
in mill. USD		 2022
IFRS
in mill. USD		 2023
IFRS
in mill. USD
Property and Equipment
  912   1,009   1,146   1,081   1,096
Intangible Assets
  552   587   607   735   712
Long-Term Investments
  43   48   -   -   10
Fixed Assets
  2,082   2,213   2,278   2,472   2,580
Inventories
  568   757   695   776   891
Accounts Receivable
  719   756   816   809   824
Cash and Cash Equivalents
  442   323   426   270   205
Current Assets
  1,848   1,922   2,094   1,999   2,100
Total Assets
  3,930   4,135   4,372   4,471   4,680

 

Liabilities

 2019
IFRS
in mill. USD		 2020
IFRS
in mill. USD		 2021
IFRS
in mill. USD		 2022
IFRS
in mill. USD		 2023
IFRS
in mill. USD
Accounts Payable
  473   470   468   476   568
Long-term debt
  48   692   725   1,135   975
Liabilities to Banks
  617   850   -   -   -
Provisions
  43   59   55   51   184
Liabilities
  1,801   1,987   1,905   2,323   2,471
Share Capital
  41   41   -   -   -
Total Equity
  2,117   2,135   2,453   2,135   2,198
Minority Interests
  12   13   14   13   11
Total liabilities equity
  3,930   4,135   4,372   4,471   4,680

 

Income Statement

 2019
IFRS
in mill. USD		 2020
IFRS
in mill. USD		 2021
IFRS
in mill. USD		 2022
IFRS
in mill. USD		 2023
IFRS
in mill. USD
Revenues
  2,207   2,341   2,553   2,517   2,875
Depreciation (total)
  -   2   -   -   -
Operating Result
  493   579   582   282   367
Interest Income
  -   -   -39   -52   -88
Income Before Taxes
  491   558   -   -   -
Income Taxes
  -4   -128   124   42   89
Minority Interests Profit
  -1   1   1   -3   2
Net Income
  486   431   421   188   190

 

Per Share

 2019
IFRS
in USD		 2020
IFRS
in USD		 2021
IFRS
in USD		 2022
IFRS
in USD		 2023
IFRS
in USD
Earnings per Share
  2.0080   1.8260   1.8230   0.8390   0.8600
Dividend per Share
  0.4400   0.5000   0.5400   0.5600   0.7200

 

Cash Flow

 2019
IFRS
in mill. USD		 2020
IFRS
in mill. USD		 2021
IFRS
in mill. USD		 2022
IFRS
in mill. USD		 2023
IFRS
in mill. USD
Cash Flow from Operating Activities
  472   464   638   530   608
Cash Flow from Investing Activities
  -151   -283   -238   -607   -333
Cash Flow from Financing
  -155   -298   -287   -58   -337
Decrease / Increase in Cash
  166   -117   -   -   -
Employees
  8,578   8,681   8,703   8,835   -